Matthew Hamilton Rosenberg’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.2K Hold
140
﹤0.01% 586
2026
Q1
$13.5K Hold
140
﹤0.01% 580
2025
Q4
$14.9K Hold
140
﹤0.01% 580
2025
Q3
$17.8K Hold
140
﹤0.01% 562
2025
Q2
$17.2K Hold
140
﹤0.01% 589
2025
Q1
$14.2K Hold
140
﹤0.01% 584
2024
Q4
$12.9K Hold
140
﹤0.01% 591
2024
Q3
$13.5K Buy
140
+100
+250% +$8.99K ﹤0.01% 584
2024
Q2
$3.41K Sell
40
-100
-71% -$8.39K ﹤0.01% 685
2024
Q1
$11.7K Sell
140
-62
-31% -$4.54K ﹤0.01% 589
2023
Q4
$13.4K Hold
202
﹤0.01% 576
2023
Q3
$13.5K Hold
202
﹤0.01% 578
2023
Q2
$13.6K Buy
202
+1
+0.5% +$63 ﹤0.01% 585
2023
Q1
$10.8K Buy
201
+1
+0.5% +$58 ﹤0.01% 651
2022
Q4
$12K Hold
200
﹤0.01% 635
2022
Q3
$9K Buy
+200
New +$10K ﹤0.01% 646

Other funds holding EHC

Matthew Hamilton Rosenberg's EHC Position: Q2 2026 in Review

Matthew Hamilton Rosenberg held its Encompass Health (EHC) position steady in Q2 2026 at 140 shares worth $14.2K. The position accounts for ﹤0.01% of the portfolio, ranked #586.

Matthew Hamilton Rosenberg first reported a position in EHC in Q3 2022 and has held it in 16 quarters since. The position peaked at $17.8K in Q3 2025. 81 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Matthew Hamilton Rosenberg held 140 shares of Encompass Health worth $14.2K as of Q2 2026.
  • Matthew Hamilton Rosenberg left its Encompass Health share count unchanged in Q2 2026.
  • Encompass Health made up ﹤0.01% of Matthew Hamilton Rosenberg's portfolio in Q2 2026, its #586 holding.
  • Matthew Hamilton Rosenberg first reported a position in Encompass Health in Q3 2022 and has held it in 16 quarters since.
  • Matthew Hamilton Rosenberg's Encompass Health position peaked at $17.8K in Q3 2025.
  • 81 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Matthew Hamilton Rosenberg's 13F filing for Q2 2026, filed 17 Jul 2026.